Login / Signup

Genome-Wide Assessment of Runs of Homozygosity in Chinese Wagyu Beef Cattle.

Guoyao ZhaoTianliu ZhangYuqiang LiuZezhao WangLei XuBo ZhuXue GaoLupei ZhangHuijiang GaoGeorge E LiuJunya LiLingyang Xu
Published in: Animals : an open access journal from MDPI (2020)
Runs of homozygosity (ROH) are continuous homozygous regions that generally exist in the DNA sequence of diploid organisms. Identifications of ROH leading to reduction in performance can provide valuable insight into the genetic architecture of complex traits. Here, we evaluated genome-wide patterns of homozygosity and their association with important traits in Chinese Wagyu beef cattle. We identified a total of 29,271 ROH segments from 462 animals. Within each animal, an average number of ROH was 63.36 while an average length was 62.19 Mb. To evaluate the enrichment of ROH across genomes, we initially identified 280 ROH regions by merging ROH events across all individuals. Of these, nine regions containing 154 candidate genes, were significantly associated with six traits (body height, chest circumference, fat coverage, backfat thickness, ribeye area, and carcass length; p < 0.01). Moreover, we found 26 consensus ROH regions with frequencies exceeding 10%, and several regions overlapped with QTLs, which are associated with body weight, calving ease, and stillbirth. Among them, we observed 41 candidate genes, including BCKDHB, MAB21L1, SLC2A13, FGFR3, FGFRL1, CPLX1, CTNNA1, CORT, CTNNBIP1, and NMNAT1, which have been previously reported to be related to body conformation, meat quality, susceptibility, and reproductive traits. In summary, we assessed genome-wide autozygosity patterns and inbreeding levels in Chinese Wagyu beef cattle. Our study identified many candidate regions and genes overlapped with ROH for several important traits, which could be unitized to assist the design of a selection mating strategy in beef cattle.
Keyphrases
  • genome wide
  • dna methylation
  • body weight
  • copy number
  • body mass index
  • gene expression
  • healthcare
  • clinical practice
  • multidrug resistant
  • health insurance
  • fatty acid
  • gram negative
  • affordable care act